Vivo Functions of Drosophila Melanogaster &Alpha

Total Page:16

File Type:pdf, Size:1020Kb

Vivo Functions of Drosophila Melanogaster &Alpha Insect Biochemistry and Molecular Biology 42 (2012) 220e229 Contents lists available at SciVerse ScienceDirect Insect Biochemistry and Molecular Biology journal homepage: www.elsevier.com/locate/ibmb Functional fat body proteomics and gene targeting reveal in vivo functions of Drosophila melanogaster a-Esterase-7 Ruth Birner-Gruenberger c, Iris Bickmeyer a, Julia Lange a,1, Philip Hehlert a,b, Albin Hermetter d, Manfred Kollroser e, Gerald N. Rechberger f, Ronald P. Kühnlein a,b,* a Abteilung Molekulare Entwicklungsbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, 37077 Göttingen, Germany b Forschungsgruppe Molekulare Physiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, 37077 Göttingen, Germany c Research Group Functional Proteomics, Institute of Pathology, and Proteomics Core Facility, Center of Medical Research, Medical University of Graz, Stiftingtalstrasse 24, 8010 Graz, Austria d Institute of Biochemistry, Graz University of Technology, Petersgasse 12, 8010 Graz, Austria e Institute of Forensic Medicine, Medical University of Graz, Universitätsplatz 4, 8010-Graz, Austria f Institute of Molecular Biosciences, Karl-Franzens-University of Graz, Humboldtstrasse 50, 8010-Graz, Austria article info abstract Article history: Carboxylesterases constitute a large enzyme family in insects, which is involved in diverse functions such Received 18 September 2011 as xenobiotic detoxification, lipid metabolism and reproduction. Phylogenetically, many insect carbox- Received in revised form ylesterases are represented by multienzyme clades, which are encoded by evolutionarily ancient gene 7 December 2011 clusters such as the a-Esterase cluster. Much in contrast to the vital importance attributed to carbox- Accepted 8 December 2011 ylesterases in general, the in vivo function of individual a-Esterase genes is largely unknown. This study employs a functional proteomics approach to identify esterolytic enzymes of the vinegar fly Drosophila Keywords: melanogaster fat body. One of the fat body carboxylesterases, a-Esterase-7, was selected for mutational Drosophila fl a a-Esterase-7 analysis by gene targeting to generate a deletion mutant y. Phenotypic characterization of -Esterase-7 fl a Mutant null mutants and transgenic ies, which overexpress a chimeric -Esterase-7:EGFP gene, reveals Insecticide important functions of a-Esterase-7 in insecticide tolerance, lipid metabolism and lifespan control. The Proteomics presented first deletion mutant of any a-Esterase in the model insect D. melanogaster generated by gene Fat body targeting not only provides experimental evidence for the endogenous functions of this gene family. It also offers an entry point for in vivo structure-function analyses of a-Esterase-7, which is of central importance for naturally occurring insecticide resistance in wild populations of various dipteran insect species. Ó 2011 Elsevier Ltd. All rights reserved. 1. Introduction family, which promotes organismal diversity during Metazoan evolution (reviewed in Oakeshott et al., 1999). Insect genomes are Carboxylesterases (CEs) play essential roles in lipid and xeno- particularly rich in CE genes and this complexity has been corre- biotic metabolism throughout the animal kingdom. The broad lated with important organismic functions such as the insecticide substrate spectrum and their complex expression profiles reflect resistance in the malaria vector Anopheles gambiae (Ranson et al., functional diversification among members of the CE multigene 2002). Overexpression has been described as one of two CE- mediated strategies for metabolic detoxification of organophos- phorous (OP) insecticides found in insecticide-resistant pop- Abbreviations: CE, carboxylesterase; D.m., Drosophila melanogaster; LD, lipid ulations of dipteran species (reviewed in Bass and Field, 2011; droplet; L.c., Lucilia cuprina; NBD-HE-HP, O-((6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) Oakeshott et al., 2005). This strategy makes use of OP seques- amino)hexanoyl)-aminoethyl-O-(n-hexyl)phosphonic acid p-nitrophenyl ester; OP, organophosphorous; qRT-PCR, quantitative reverse transcription PCR; s.e.m., stan- tering to protect against the neurotoxic effect of the insecticides dard error of the mean. on their target, acetylcholinesterase. Alternatively, CE mutants * Corresponding author. Forschungsgruppe Molekulare Physiologie, Max-Planck- with novel substrate spectrum are employed to detoxify OP Institut für biophysikalische Chemie, Am Fassberg 11, 37077 Göttingen, Germany. insecticides by hydrolytic cleavage (see Section 4). Generally, Tel.: þ49 (0) 551 2011045, fax: þ49 (0) 551 2011755. much in contrast to the vital general importance of CEs, functional E-mail address: [email protected] (R.P. Kühnlein). 1 Present address: ICON Clinical Research, Heinrich-Hertz-Straße 26, 63225 information about the in vivo role of particular CE family members Langen, Germany. is limited. 0965-1748/$ e see front matter Ó 2011 Elsevier Ltd. All rights reserved. doi:10.1016/j.ibmb.2011.12.004 R. Birner-Gruenberger et al. / Insect Biochemistry and Molecular Biology 42 (2012) 220e229 221 Electrophoretic zymograms of adult Drosophila melanogaster determined (Bio-Rad Protein Assay #500-0006) and adjusted to flies identified 22 soluble esterase isozymes, among them ten CEs 0.5 mg/ml. Homogenates were incubated with 20 mM the fluorescent (Healy et al., 1991). On the other hand computational annotation of activity-based probe O-((6-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) the fly genome lists 35 genes, which encode enzymes with exper- amino)hexanoyl)aminoethyl-O-(n-hexyl)phosphonic acid p-nitro- imentally supported or predicted carboxylesterase activity (GO phenyl ester (NBD-HE-HP) (synthesized as published in Oskolkova term 0004091; Tweedie et al., 2009; www.flybase.org). Among et al., 2003; Schmidinger et al., 2005) and 1 mM Triton X-100 for 2 h them are the ten genes (a-Est1-10) of the a-Esterase cluster located at 28 C with mild shaking (550 rpm), quick-frozen in liquid on the right arm of chromosome 3. Recently, the first two a-Est nitrogen and kept at À20 C until further use. Unlabeled controls genes were assigned to esterase isozyme activities, i.e. a-Est5 to were also tested to exclude autofluorescent proteins. Proteins were EST9 and a-Est7 to EST23 by peptide fingerprinting combined with precipitated with 10% trichloroacetic acid (w/v) and subjected to recombinant protein expression (Campbell et al., 2003). This SDS-PAGE in Tris/glycine buffer (5% stacking gel, 10% resolving gel) approach started to link the wealth of biochemical information on or 2D-gel electrophoresis (pH 3e10 NL IPG strips; 10% SDS-PAGE) EST isozymes to the molecular identity of the corresponding genes. for detection of fluorescent NBD-HE-HP-labeled protein bands/ However, the in vivo roles of individual a-Est cluster genes remains spots by laser scanning as described (Birner-Gruenberger et al., obscure as none of them has been functionally characterized by 2005). Relative fluorescence intensity spot volumes were deter- mutant analysis. mined using Delta2D 4.0.8 software for spot detection and quan- Correlational analyses support diverse functions for a-Est genes. titation after normalization on the total fluorescence intensity of all For example, a-Est1, a-Est2 and a-Est8 have a pronounced expres- detected spots. sion in adult fly heads (Campbell et al., 2003; Chintapalli et al., Protein spots were excised from gels and tryptically digested 2007). In heads of adult males a-Est1 and a-Est8 are transcrip- according to the method by Shevchenko et al. (1996). Peptide tionally up-regulated in fly lines selected for aggressive behavior extracts were dissolved in 0.1% formic acid, separated by nano- (Dierick and Greenspan, 2006) and a-Est2 behaves as a mating- HPLC and analyzed by LC-MS/MS with a Thermo-Finnigan LTQ responsive gene (Ellis and Carney, 2010). Moreover, the a-EST2 linear iontrap mass spectrometer as described (Birner-Gruenberger and a-EST7 proteins are members of the fat body lipid droplet et al., 2008). Proteins were identified by searching the D. mela- proteome (Beller et al., 2006) suggesting a role in lipid metabolism. nogaster NCBI non-redundant public database with SpectrumMill Notably, seven of the ten a-Esterase cluster genes are at least Rev. 03.03.078 (Agilent). Acceptance parameters were two or more moderately expressed in the Drosophila fat body (Chintapalli et al., identified distinct peptides according to the parameters defined by 2007). Multiple a-Est gene expression in the fat body highlights its Carr et al. (2004) except for the single high confident peptide of a- central role of this organ as a metabolic hub in insects. Besides its EST2 (see Fig. S1). most prominent role as major energy storage organ, the fat body is involved in vital organismal functions such as immunity, growth 2.2. Esterase activity assay control and detoxification. The role of particular esterase activities in these processes awaits clarification. Fat body cell homogenates were essentially prepared as This study employs a functional proteomics approach to described in Section 2.1. Specific total esterase activity was deter- molecularly identify esterases of the Drosophila fat body. Tissue mined from the linear increase of absorbance at 405 nm of p- profiling for esterase activities with subsequent enzyme identifi- nitrophenolate released from 100 mM p-nitrophenyl butyrate in cation via mass spectrometry has been successfully applied to 20 mM TriseHCl, pH8, 150 mM NaCl and 0.01%Triton X-100 (Shirai characterize
Recommended publications
  • ) (51) International Patent Classification: Columbia V5G 1G3
    ) ( (51) International Patent Classification: Columbia V5G 1G3 (CA). PANDEY, Nihar R.; 10209 A 61K 31/4525 (2006.01) C07C 39/23 (2006.01) 128A St, Surrey, British Columbia V3T 3E7 (CA). A61K 31/05 (2006.01) C07D 405/06 (2006.01) (74) Agent: ZIESCHE, Sonia et al.; Gowling WLG (Canada) A61P25/22 (2006.01) LLP, 2300 - 550 Burrard Street, Vancouver, British Colum¬ (21) International Application Number: bia V6C 2B5 (CA). PCT/CA2020/050165 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection av ailable) . AE, AG, AL, AM, 07 February 2020 (07.02.2020) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (25) Filing Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (26) Publication Language: English HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (30) Priority Data: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 16/270,389 07 February 2019 (07.02.2019) US OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (63) Related by continuation (CON) or continuation-in-part SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, (CIP) to earlier application: TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW. US 16/270,389 (CON) (84) Designated States (unless otherwise indicated, for every Filed on 07 Februaiy 2019 (07.02.2019) kind of regional protection available) .
    [Show full text]
  • TITLE PAGE Oxidative Stress and Response to Thymidylate Synthase
    Downloaded from molpharm.aspetjournals.org at ASPET Journals on October 2, 2021 -Targeted -Targeted 1 , University of of , University SC K.W.B., South Columbia, (U.O., Carolina, This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted.
    [Show full text]
  • The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z
    REVIEW pubs.acs.org/CR The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z. Long* and Benjamin F. Cravatt* The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States CONTENTS 2.4. Other Phospholipases 6034 1. Introduction 6023 2.4.1. LIPG (Endothelial Lipase) 6034 2. Small-Molecule Hydrolases 6023 2.4.2. PLA1A (Phosphatidylserine-Specific 2.1. Intracellular Neutral Lipases 6023 PLA1) 6035 2.1.1. LIPE (Hormone-Sensitive Lipase) 6024 2.4.3. LIPH and LIPI (Phosphatidic Acid-Specific 2.1.2. PNPLA2 (Adipose Triglyceride Lipase) 6024 PLA1R and β) 6035 2.1.3. MGLL (Monoacylglycerol Lipase) 6025 2.4.4. PLB1 (Phospholipase B) 6035 2.1.4. DAGLA and DAGLB (Diacylglycerol Lipase 2.4.5. DDHD1 and DDHD2 (DDHD Domain R and β) 6026 Containing 1 and 2) 6035 2.1.5. CES3 (Carboxylesterase 3) 6026 2.4.6. ABHD4 (Alpha/Beta Hydrolase Domain 2.1.6. AADACL1 (Arylacetamide Deacetylase-like 1) 6026 Containing 4) 6036 2.1.7. ABHD6 (Alpha/Beta Hydrolase Domain 2.5. Small-Molecule Amidases 6036 Containing 6) 6027 2.5.1. FAAH and FAAH2 (Fatty Acid Amide 2.1.8. ABHD12 (Alpha/Beta Hydrolase Domain Hydrolase and FAAH2) 6036 Containing 12) 6027 2.5.2. AFMID (Arylformamidase) 6037 2.2. Extracellular Neutral Lipases 6027 2.6. Acyl-CoA Hydrolases 6037 2.2.1. PNLIP (Pancreatic Lipase) 6028 2.6.1. FASN (Fatty Acid Synthase) 6037 2.2.2. PNLIPRP1 and PNLIPR2 (Pancreatic 2.6.2.
    [Show full text]
  • Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators S
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/10/10/jpet.118.252296.DC1 1521-0103/367/3/494–508$35.00 https://doi.org/10.1124/jpet.118.252296 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 367:494–508, December 2018 Copyright ª 2018 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license. Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators s Jason R. Clapper, Cassandra L. Henry, Micah J. Niphakis, Anna M. Knize, Aundrea R. Coppola, Gabriel M. Simon, Nhi Ngo, Rachel A. Herbst, Dylan M. Herbst, Alex W. Reed, Justin S. Cisar, Olivia D. Weber, Andreu Viader, Jessica P. Alexander, Mark L. Cunningham, Todd K. Jones, Iain P. Fraser, Cheryl A. Grice, R. Alan B. Ezekowitz, ’ Gary P. O Neill, and Jacqueline L. Blankman Downloaded from Abide Therapeutics, San Diego, California Received July 26, 2018; accepted October 5, 2018 ABSTRACT Monoacylglycerol lipase (MGLL) is the primary degradative whether selective MGLL inhibition would affect prostanoid pro- jpet.aspetjournals.org enzyme for the endocannabinoid 2-arachidonoylglycerol (2- duction in several human assays known to be sensitive AG). The first MGLL inhibitors have recently entered clinical to cyclooxygenase inhibitors. ABD-1970 robustly elevated brain development for the treatment of neurologic disorders. To 2-AG content and displayed antinociceptive and antipru- support this clinical path, we report the pharmacological ritic activity in a battery of rodent models (ED50 values of characterization of the highly potent and selective MGLL inhibitor 1–2 mg/kg).
    [Show full text]
  • Sox2 Promotes Malignancy in Glioblastoma by Regulating
    Volume 16 Number 3 March 2014 pp. 193–206.e25 193 www.neoplasia.com Artem D. Berezovsky*, Laila M. Poisson†, Sox2 Promotes Malignancy in ‡ ‡ David Cherba , Craig P. Webb , Glioblastoma by Regulating Andrea D. Transou*, Nancy W. Lemke*, Xin Hong*, Laura A. Hasselbach*, Susan M. Irtenkauf*, Plasticity and Astrocytic Tom Mikkelsen*,§ and Ana C. deCarvalho* Differentiation1,2 *Department of Neurosurgery, Henry Ford Hospital, Detroit, MI; †Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI; ‡Program of Translational Medicine, Van Andel Research Institute, Grand Rapids, MI; §Department of Neurology, Henry Ford Hospital, Detroit, MI Abstract The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early development to adult tissues. Sox2 can reprogram differentiated cells into pluripotent cells in concert with other factors and is overexpressed in various cancers. In glioblastoma (GBM), Sox2 is a marker of cancer stemlike cells (CSCs) in neurosphere cultures and is associated with the proneural molecular subtype. Here, we report that Sox2 expression pattern in GBM tumors and patient-derived mouse xenografts is not restricted to a small percentage of cells and is coexpressed with various lineage markers, suggesting that its expression extends beyond CSCs to encompass more differentiated neoplastic cells across molecular subtypes. Employing a CSC derived from a patient with GBM and isogenic differentiated cell model, we show that Sox2 knockdown in the differentiated state abolished dedifferentiation and acquisition of CSC phenotype. Furthermore, Sox2 deficiency specifically impaired the astrocytic component of a biphasic gliosarcoma xenograft model while allowing the formation of tumors with sarcomatous phenotype.
    [Show full text]
  • The Molecular Biology of Pancreatic Adenocarcinoma: Translational Challenges and Clinical Perspectives
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives Shun Wang1, Yan Zheng1, Feng Yang2, Le Zhu1, Xiao-Qiang Zhu3, Zhe-Fang Wang4, Xiao-Lin Wu4, Cheng-Hui Zhou4, Jia-Yan Yan4,5, Bei-Yuan Hu1, Bo Kong6, De-Liang Fu2, Christiane Bruns4, Yue Zhao4, Lun-Xiu Qin1 and Qiong-Zhu Dong 1,7 Pancreatic cancer is an increasingly common cause of cancer mortality with a tight correspondence between disease mortality and incidence. Furthermore, it is usually diagnosed at an advanced stage with a very dismal prognosis. Due to the high heterogeneity, metabolic reprogramming, and dense stromal environment associated with pancreatic cancer, patients benefit little from current conventional therapy. Recent insight into the biology and genetics of pancreatic cancer has supported its molecular classification, thus expanding clinical therapeutic options. In this review, we summarize how the biological features of pancreatic cancer and its metabolic reprogramming as well as the tumor microenvironment regulate its development and progression. We further discuss potential biomarkers for pancreatic cancer diagnosis, prediction, and surveillance based on novel liquid biopsies. We also outline recent advances in defining pancreatic cancer subtypes and subtype-specific therapeutic responses and current preclinical therapeutic models. Finally, we discuss prospects and challenges in the clinical development of pancreatic cancer therapeutics.
    [Show full text]
  • Liquid Biopsy Biomarkers in Bladder Cancer: a Current Need for Patient Diagnosis and Monitoring
    Review Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring Iris Lodewijk 1,2, Marta Dueñas 1,2,3, Carolina Rubio 1,2,3, Ester Munera-Maravilla 1,2, Cristina Segovia 1,2,3, Alejandra Bernardini 1,2,3, Alicia Teijeira 1, Jesús M. Paramio 1,2,3 and Cristian Suárez-Cabrera 1,2,* 1 Molecular Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Avenida Complutense nº 40, 28040 Madrid, Spain; [email protected] (I.L.); [email protected] (M.D.); [email protected] (C.R.); [email protected] (E.M.-M.); [email protected] (C.S.); [email protected] (A.B.); [email protected] (A.T.); [email protected] (J.M.P.) 2 Biomedical Research Institute I+12, University Hospital “12 de Octubre”, Av Córdoba s/n, 28041 Madrid, Spain 3 Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-91-496-6438 Received: 28 July 2018; Accepted: 21 August 2018; Published: 24 August 2018 Abstract: Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence and recurrence rates, as well as the limited advances in effective disease management. Currently, a combination of cytology and cystoscopy is the routinely used methodology for diagnosis, prognosis and disease surveillance. However, both the poor sensitivity of cytology tests as well as the high invasiveness and big variation in tumour stage and grade interpretation using cystoscopy, emphasizes the urgent need for improvements in BC clinical guidance.
    [Show full text]
  • The Dark Side of the Human Genome
    TECHNOLOGY FEATURE THE DARK SIDE OF THE HUMAN GENOME Scientists are uncovering the hidden switches in our genome that dial gene expression up and down, but much work lies ahead to peel back the many layers of regulation. MEHAU KULYK/SPL MEHAU The human genome is not packed with ‘junk’ as previously thought, but with regulatory regions that modulate gene activity. BY KELLY RAE CHI expression in ways that scientists are only of non-coding portions, that drive when and starting to unravel. By uncovering regulatory where genes are expressed. Scientists have ifteen years ago, scientists celebrated instructions in the genome beyond protein- generated a list of such elements by using bio- the first draft of the sequenced human coding genes, scientists are hoping to yield chemical assays to probe DNA sequences, RNA genome. At the time, they predicted that new ways to understand and treat disease. “It’s transcripts, regulatory proteins bound to DNA Fhumans had between 25,000 and 40,000 genes not overstating to say that ENCODE is as sig- and RNA and epigenetic signatures — the chem- that code for proteins. That estimate has con- nificant for our understanding of the human ical tags on DNA and the proteins packaging it tinued to fall. Humans actually seem to have genome as the original DNA sequencing of the — that also affect gene expression. as few as 19,000 such genes1 — a mere 1–2% of human genome,” says cell biologist Bing Ren of So far, the data suggest that there are the genome. The key to our complexity lies in the University of California, San Diego, Insti- hundreds of thousands of functional regions how these genes are regulated by the remain- tute for Genomic Medicine in La Jolla, who is in the human genome whose task is to control ing 99% of our DNA, known as the genome’s a member of the ENCODE team.
    [Show full text]
  • Source: the Arabidopsis Information Resource (TAIR);
    Table S1 List of targeted loci and information about their function in Arabidopsis thaliana (source: The Arabidopsis Information Resource (TAIR); https://www.arabidopsis.org/tools/bulk/genes/index.jsp). Locus Gene Model Gene Model Description Gene Model Primary Gene Symbol All Gene Symbols Identifier Name Type AT1G78800 AT1G78800.1 UDP-Glycosyltransferase superfamily protein_coding protein;(source:Araport11) AT5G06830 AT5G06830.1 hypothetical protein;(source:Araport11) protein_coding AT2G31740 AT2G31740.1 S-adenosyl-L-methionine-dependent methyltransferases protein_coding superfamily protein;(source:Araport11) AT5G11960 AT5G11960.1 magnesium transporter, putative protein_coding (DUF803);(source:Araport11) AT4G00560 AT4G00560.4 NAD(P)-binding Rossmann-fold superfamily protein_coding protein;(source:Araport11) AT1G80510 AT1G80510.1 Encodes a close relative of the amino acid transporter ANT1 protein_coding (AT3G11900). AT2G21250 AT2G21250.1 NAD(P)-linked oxidoreductase superfamily protein_coding protein;(source:Araport11) AT5G04420 AT5G04420.1 Galactose oxidase/kelch repeat superfamily protein_coding protein;(source:Araport11) AT4G34910 AT4G34910.1 P-loop containing nucleoside triphosphate hydrolases protein_coding superfamily protein;(source:Araport11) AT5G66120 AT5G66120.2 3-dehydroquinate synthase;(source:Araport11) protein_coding AT1G45110 AT1G45110.1 Tetrapyrrole (Corrin/Porphyrin) protein_coding Methylase;(source:Araport11) AT1G67420 AT1G67420.2 Zn-dependent exopeptidases superfamily protein_coding protein;(source:Araport11) AT3G62370
    [Show full text]
  • New Insights on Human Essential Genes Based on Integrated Multi
    bioRxiv preprint doi: https://doi.org/10.1101/260224; this version posted February 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. New insights on human essential genes based on integrated multi- omics analysis Hebing Chen1,2, Zhuo Zhang1,2, Shuai Jiang 1,2, Ruijiang Li1, Wanying Li1, Hao Li1,* and Xiaochen Bo1,* 1Beijing Institute of Radiation Medicine, Beijing 100850, China. 2 Co-first author *Correspondence: [email protected]; [email protected] Abstract Essential genes are those whose functions govern critical processes that sustain life in the organism. Comprehensive understanding of human essential genes could enable breakthroughs in biology and medicine. Recently, there has been a rapid proliferation of technologies for identifying and investigating the functions of human essential genes. Here, according to gene essentiality, we present a global analysis for comprehensively and systematically elucidating the genetic and regulatory characteristics of human essential genes. We explain why these genes are essential from the genomic, epigenomic, and proteomic perspectives, and we discuss their evolutionary and embryonic developmental properties. Importantly, we find that essential human genes can be used as markers to guide cancer treatment. We have developed an interactive web server, the Human Essential Genes Interactive Analysis Platform (HEGIAP) (http://sysomics.com/HEGIAP/), which integrates abundant analytical tools to give a global, multidimensional interpretation of gene essentiality. bioRxiv preprint doi: https://doi.org/10.1101/260224; this version posted February 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Long Non-Coding RNA ABHD11-AS1 Promotes Colorectal Cancer
    www.aging-us.com AGING 2021, Vol. 13, No. 16 Research Paper Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway Jia Luo1,*, Yigui Jiang1,*, Lianhui Wu2,*, Dexiang Zhuo3, Shengjun Zhang1, Xiang Jiang4, Yingming Sun5, Yue Huang1,2 1Department of Gastroenterology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming 365000, Fujian, China 2Department of Endoscope Room, Affiliated Sanming First Hospital of Fujian Medical University, Sanming 365000, Fujian, China 3Department of Clinical Laboratory, Affiliated Sanming First Hospital of Fujian Medical University, Sanming 365000, Fujian, China 4Department of Gynecology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming 365000, Fujian, China 5Department of Medical and Radiation Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming 365000, Fujian, China *Equal contribution Correspondence to: Yingming Sun, Yue Huang; email: [email protected], [email protected], https://orcid.org/0000- 0002-4798-1630 Keywords: colorectal cancer, lncRNA-ABHD11-AS1, PI3K/Akt pathway, oncogene profile Received: September 19, 2020 Accepted: July 6, 2021 Published: August 10, 2021 Copyright: © 2021 Luo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Long non-coding (lnc)RNA ABHD11-AS1 participates in the development and progress of various cancers, but its role in colorectal cancer (CRC) remains poorly known. In the present study, public database analysis and quantitative reverse transcription PCR of CRC and normal tissues showed that ABHD11-AS1 was overexpressed in CRC and associated with poor prognosis in CRC patients.
    [Show full text]
  • The Important Role of N6-Methyladenosine RNA Modification in Non-Small Cell Lung Cancer
    G C A T T A C G G C A T genes Review The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer Yue Cheng †, Meiqi Wang †, Junliang Zhou, Huanhuan Dong, Shuqing Wang and Hui Xu * Department of Clinical Laboratory, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150081, China; [email protected] (Y.C.); [email protected] (M.W.); [email protected] (J.Z.); [email protected] (H.D.); [email protected] (S.W.) * Correspondence: [email protected] † Shared first authorship. Abstract: N6-methyladenosine (m6A) is one of the most prevalent epigenetic modifications of eukaryotic RNA. The m6A modification is a dynamic and reversible process, regulated by three kinds of regulator, including m6A methyltransferases, demethylases and m6A-binding proteins, and this modification plays a vital role in many diseases, especially in cancers. Accumulated evidence has proven that this modification has a significant effect on cellular biological functions and cancer progression; however, little is known about the effects of the m6A modification in non-small cell lung cancer (NSCLC). In this review, we summarized how various m6A regulators modulate m6A RNA metabolism and demonstrated the effect of m6A modification on the progression and cellular biological functions of NSCLC. We also discussed how m6A modification affects the treatment, drug resistance, diagnosis and prognosis of NSCLC patients. 6 6 Citation: Cheng, Y.; Wang, M.; Zhou, Keywords: N6-methyladenosine (m A); methyltransferases; demethylases; m A-binding proteins; J.; Dong, H.; Wang, S.; Xu, H. The NSCLC Important Role of N6- methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
    [Show full text]